Universite Dé Lorraine

Université Henri Poincaré-Nancy I

Bristol-myers Squibb Compnay

Novo Nordisk A/s

Bristol-myers Squibb

Université Henri Poincaré Nancy 1

Gilbert Faure

Sebastien Gibot

Paola Panina

Nadia Passini

Marie Nathalie Kolopp-Sarda

Marie-Christine Bene

Pietro Di Lucia

Bruno Levy

Pierre-Edouard Bollaert

A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterised by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.

Therapeutic TREM-1 peptides

A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.

The present invention concerns a method of diagnosing disease of bacterial or fungal origin in a subject, which method comprises the step of measuring the level of Strem-1 in a biological sample obtained from said subject.

Method of diagnosing infectious disease by measuring the level of soluble TREM-1 in a sample

Therapeutic peptides and method

Growing community of inventors

Vandoeuvre les Nancy, France

Gilbert Faure